ProShare Advisors’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $235K | Sell |
|
|||||
|
2025
Q1 | $189K | Sell |
|
|||||
|
2024
Q4 | $389K | Buy |
|
|||||
|
2024
Q3 | $497K | Buy |
|
|||||
|
2024
Q2 | $402K | Sell |
|
|||||
|
2024
Q1 | $639K | Buy |
|
|||||
|
2023
Q4 | $633K | Buy |
|
|||||
|
2023
Q3 | $552K | Buy |
|
|||||
|
2023
Q2 | $709K | Buy |
|
|||||
|
2023
Q1 | $607K | Sell |
|
|||||
|
2022
Q4 | $654K | Buy |
|
|||||
|
2022
Q3 | $890K | Buy |
|
|||||
|
2022
Q2 | $804K | Sell |
|
|||||
|
2022
Q1 | $1.63M | Sell |
|
|||||
|
2021
Q4 | $3.25M | Buy |
|
|||||
|
2021
Q3 | $3.51M | Sell |
|
|||||
|
2021
Q2 | $4.67M | Buy |
|
|||||
|
2021
Q1 | $1.93M | Buy |
|
|||||
|
2020
Q4 | $1.1M | Buy |
|
|||||
|
2020
Q3 | $310K | Buy |
|
|||||
|
2020
Q2 | $298K | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $232K | Sell |
|
|||||
|
2019
Q3 | $235K | Buy |
|
|||||
|
2019
Q2 | $276K | Sell |
|
|||||
|
2019
Q1 | $324K | Buy |
|
|||||
|
2018
Q4 | $249K | Sell |
|
|||||
|
2018
Q3 | $620K | Sell |
|
|||||
|
2018
Q2 | $615K | Buy |
|
|||||
|
2018
Q1 | $458K | Sell |
|
|||||
|
2017
Q4 | $486K | Buy |
|
|||||
|
2017
Q3 | $530K | Buy |
|
|||||
|
2017
Q2 | $316K | Sell |
|
|||||
|
2017
Q1 | $282K | Sell |
|
|||||
|
2016
Q4 | $326K | Buy |
|